|
1
|
Foran JM and Shammo JM: Clinical
presentation, diagnosis and prognosis of myelodysplastic syndromes.
Am J Med. 125(Suppl 7): S6–S13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou T, Hasty P, Walter CA, Bishop AJ,
Scott LM and Rebel VI: Myelodysplastic syndrome: An inability to
appropriately respond to damaged DNA? Exp Hematol. 41:665–674.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pilo F, Di Tucci AA, Dessalvi P, Caddori A
and Angelucci E: The evolving clinical scenario of myelodysplastic
syndrome: The need for a complete and up to date upfront diagnostic
assessment. Eur J Intern Med. 21:490–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li JN: Myelodysplastic syndrome
hematopoietic stem cell. Int J Cancer. 133:525–533. 2013.
View Article : Google Scholar
|
|
5
|
Garcia-Manero G: Myelodysplastic
syndromes: 2012 update on diagnosis, risk-stratification and
management. Am J Hematol. 87:692–701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma X: Epidemiology of myelodysplastic
syndromes. Am J Med. 125(Suppl 7): S2–S5. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Voso MT, Santini V, Finelli C, Musto P,
Pogliani E, Angelucci E, Fioritoni G, Alimena G, Maurillo L,
Cortelezzi A, et al: Valproic acid at therapeutic plasma levels may
increase 5-azacytidine efficacy in higher risk myelodysplastic
syndromes. Clin Cancer Res. 15:5002–5007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Z, Teruya K, Eto H and Shirahata S:
Induction of apoptosis by low-molecular-weight fucoidan through
calcium- and caspase-dependent mitochondrial pathways in MDA-MB-231
breast cancer cells. Biosci Biotechnol Biochem. 77:235–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nobili S, Lippi D, Witort E, Donnini M,
Bausi L, Mini E and Capaccioli S: Natural compounds for cancer
treatment and prevention. Pharmacol Res. 59:365–378. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu L, Heinrich M, Myers S and Dworjanyn
SA: Towards a better understanding of medicinal uses of the brown
seaweed sargassum in traditional Chinese medicine: A phytochemical
and pharmacological review. J Ethnopharmacol. 142:591–619. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu C, Cao R, Zhang SX, Man YN and Wu XZ:
Fucoidan inhibits the growth of hepatocellular carcinoma
independent of angiogenesis. Evid Based Complement Alternat Med.
2013:6925492013.PubMed/NCBI
|
|
12
|
Yang L, Wang P, Wang H, Li Q, Teng H, Liu
Z, Yang W, Hou L and Zou X: Fucoidan derived from Undaria
pinnatifida induces apoptosis in human hepatocellular carcinoma
SMMC-7721 cells via the ROS-mediated mitochondrial pathway. Mar
Drugs. 11:1961–1976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ermakova S, Sokolova R, Kim SM, Um BH,
Isakov V and Zvyagintseva T: Fucoidans from brown seaweeds
Sargassum hornery, Eclonia cava, Costaria costata: Structural
characteristics and anticancer activity. Appl Biochem Biotechnol.
164:841–850. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fulda S: Modulation of apoptosis by
natural products for cancer therapy. Planta Med. 76:1075–1079.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Luo J, Nian Q, Xiao Q, Yang Z and
Liu L: Ribosomal protein S14 silencing inhibits growth of acute
myeloid leukemia transformed from myelodysplastic syndromes via
activating p53. Hematology. 19:225–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thinh PD, Menshova RV, Ermakova SP,
Anastyuk SD, Ly BM and Zvyagintseva TN: Structural characteristics
and anticancer activity of fucoidan from the brown alga sargassum
mcclurei. Mar Drugs. 11:1456–1476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xue M, Ge Y, Zhang J, Wang Q, Hou L, Liu
Y, Sun L and Li Q: Anticancer properties and mechanisms of fucoidan
on mouse breast cancer in vitro and in vivo. Plos One.
7:e434832012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teruya T, Konishi T, Uechi S, Tamaki H and
Tako M: Anti-proliferative activity of oversulfated fucoidan from
commercially cultured Cladosiphon okamuranus Tokida in U937 cells.
Int J Biol Macromol. 41:221–226. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boo HJ, Hong JY, Kim SC, Kang JI, Kim MK,
Kim EJ, Hyun JW, Koh YS, Yoo ES, Kwon JM and Kang HK: The
anticancer effect of fucoidan in PC-3 prostate cancer cells. Mar
Drugs. 11:2982–2999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xue M, Ge Y, Zhang J, Liu Y, Wang Q, Hou L
and Zheng Z: Fucoidan inhibited 4T1 mouse breast cancer cell growth
in vivo and in vitro via downregulation of Wnt/beta-catenin
signaling. Nutr Cancer. 65:460–468. 2013. View Article : Google Scholar
|
|
21
|
Boo HJ, Hong JY, Kim SC, Kang JI, Kim MK,
Kim EJ, Hyun JW, Koh YS, Yoo ES, Kwon JM and Kang HK: The
anticancer effect of fucoidan in PC-3 prostate cancer cells. Mar
Drugs. 11:2982–2999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Teruya K, Eto H and Shirahata S:
Fucoidan extract induces apoptosis in MCF-7 cells via a mechanism
involving the ROS-dependent JNK activation and
mitochondria-mediated pathways. PLoS One. 6:e274412011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park HS, Hwang HJ, Kim GY, Cha HJ, Kim WJ,
Kim ND, Yoo YH and Choi YH: Induction of apoptosis by fucoidan in
human leukemia U937 cells through activation of p38 MAPK and
modulation of Bcl-2 family. Mar Drugs. 11:2347–2364. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Senthilkumar K, Manivasagan P, Venkatesan
J and Kim SK: Brown seaweed fucoidan: Biological activity and
apoptosis, growth signaling mechanism in cancer. Int J Biol
Macromol. 60:366–374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Budihardjo I, Oliver H, Lutter M, Luo X
and Wang X: Biochemical pathways of caspase activation during
apoptosis. Annu Rev Cell Dev Biol. 15:269–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin S, Pang RP, Shen JN, Huang G, Wang J
and Zhou JG: Grifolin induces apoptosis via inhibition of PI3K/AKT
signalling pathway in human osteosarcoma cells. Apoptosis.
12:1317–1326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Quan Z, Gu J, Dong P, Lu J, Wu X, Wu W,
Fei X, Li S, Wang Y, Wang J and Liu Y: Reactive oxygen
species-mediated endoplasmic reticulum stress and mitochondrial
dysfunction contribute to cirsimaritin-induced apoptosis in human
gallbladder carcinoma GBC-SD cells. Cancer Lett. 295:252–259. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pelicano H, Feng L, Zhou Y, Carew JS,
Hileman EO, Plunkett W, Keating MJ and Huang P: Inhibition of
mitochondrial respiration: A novel strategy to enhance drug-induced
apoptosis in human leukemia cells by a reactive oxygen
species-mediated mechanism. J Biol Chem. 278:37832–37839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang L, Wang P, Wang H, Li Q, Teng H, Liu
Z, Yang W, Hou L and Zou X: Fucoidan derived from Undaria
pinnatifida induces apoptosis in human hepatocellular carcinoma
SMMC-7721 cells via the ROS-mediated mitochondrial pathway. Mar
Drugs. 11:1961–1976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang P, Feng L, Oldham EA, Keating MJ and
Plunkett W: Superoxide dismutase as a target for the selective
killing of cancer cells. Nature. 407:390–395. 2000. View Article : Google Scholar : PubMed/NCBI
|
